Scinai awarded israel innovation authority grant to expand fill-and-finish cdmo capabilities

Grant funds two-thirds of a nis 1.23 million ($373k) project to strengthen scinai bioservices' small-batch fill and finish capabilities, addressing a critical need among early-stage biotech companies in israel and abroad jerusalem , oct. 6, 2025 /prnewswire/ -- scinai immunotherapeutics ltd. (nasdaq: scni) ("scinai" or the "company"), a biopharmaceutical company with a growing boutique contract development and manufacturing organization (cdmo) business unit, scinai bioservices, today announced that it has been awarded a non-dilutive grant of approximately nis 809,000 (about $246,000) from the israel innovation authority (iia).
CDMO Ratings Summary
CDMO Quant Ranking